Jail Medication for Opioid Use Disorder Program: Process and Outcome Evaluation | Kittitas County Jail, WA

This report evaluates the Kittitas County Jail’s medication-assisted treatment (MAT) program for opioid use disorder (OUD), which starts people on buprenorphine and naloxone in jail and connects them to continued treatment in the community. Researchers at Central Washington University prepared the report in January 2025. The evaluation has two parts. The process evaluation measures how well the program lines up with the Substance Abuse and Mental Health Services Administration (SAMHSA) 2019 guide, Use of Medication-Assisted Treatment for Opioid Use Disorder in Criminal Justice Settings. The outcome evaluation compares jail and community data from the 816 days before the program was fully running with the 816 days that followed, starting July 6, 2021.


Who might use it

Jail administrators, jail-based MAT program coordinators, and Comprehensive Opioid, Stimulant, and Substance Use Program (COSSUP) project directors who are planning or already running an evaluation of medication for OUD in a correctional setting can use this report. University and research partners, local health departments, treatment providers, reentry coalitions, and rural counties building partnerships to continue MAT after release may also find it useful.

How to use it

The report gives other jails a ready-made model for evaluating their own MAT programs. For the process evaluation, the researchers broke the SAMHSA guide into key elements, turned each element into focus group questions, and held separate focus groups with community members, jail staff, and treatment providers. The appendix shows the full crosswalk from SAMHSA guidance to evaluation questions, so another site can reuse it as a starting point. Each element was then rated as exceeds, meets, or needs improvement. Kittitas County met or exceeded the standard on 12 of 21 elements, including buprenorphine prescriber waivers, eligibility, cost coverage, and safety practices. The nine elements that needed improvement were workforce and staffing, medication costs in the community, police-led diversion, reentry and housing, medication-assisted withdrawal, jail staff understanding of program policies, counseling at 12 months, dosage and tapering, and community stigma.

The outcome evaluation shows what a small rural jail can learn by linking jail records with treatment provider data. The evaluators found that no MAT participant died of an overdose during the study period, and the jail recorded no buprenorphine contraband confiscations in either time period. The linked data also exposed a drop-off after release: of 63 people released to the community, 45 were referred to community MAT, 21 attended a first appointment, and 10 had a documented post-release refill. Agencies can borrow this approach to track their own referral-to-refill pathway, and they can use the report’s method of recording recidivism by type (technical violation, court order violation, new arrest) rather than as a simple yes or no. The authors recommend a post-release case manager, or “boundary spanner,” to coordinate services after release, and they note that missing data, small numbers, and the overlap with COVID-19 jail policies limit what the results can show about cause and effect. Readers should keep those limits in mind when citing the findings.

Next
Next

Jail MOUD Screening & Intake SOP and Assessment Forms | Kittitas County, WA